Search results for "Micro"

showing 10 items of 23412 documents

Unusual recurrence of trigeminal neuralgia after microvascular decompression by muscle interposal.

2011

Summary Background Patients with trigeminal neuralgia (TN) and persistent or recurrent facial pain after microvascular decompression (MVD) typically undergo less invasive procedures in the hope of providing pain relief. However, re-operation should be considered in selected patients. Case Report A 48-year-old woman presented with recurrent trigeminal neuralgia (TN) 3 years following microvascular decompression (MVD). The patient underwent brain magnetic resonance angiography (MRA), which did not reveal neurovascular compression; therefore surgical re-exploration was carried out. During the operation, the fifth cranial nerve was seen without impingement from any blood vessels; however, a ver…

medicine.medical_specialtymicrovascular decompressionrecurrenceDecompressionmedicine.medical_treatmentRadiographyLess invasiveMicrovascular decompressionTrigeminal neuralgiaNeurovascular compressionmedicineHumansPeriosteumIntraoperative Caremedicine.diagnostic_testCase Studytrigeminal neuralgiaSettore MED/27 - Neurochirurgiabusiness.industryMedicine (all)MusclesGeneral MedicineMiddle Agedmedicine.diseaseDecompression SurgicalSurgeryRadiographymedicine.anatomical_structureTrigeminal neuralgia microvascular decompressionAngiographyMicrovesselsFemalebusiness
researchProduct

Microvascular Obstruction in ST-Segment Elevation Myocardial Infarction: Looking Back to Move Forward. Focus on CMR

2019

After a myocardial infarction (MI), despite the resolution of the coronary occlusion, the deterioration of myocardial perfusion persists in a considerable number of patients. This phenomenon is known as microvascular obstruction (MVO). Initially, the focus was placed on re-establishing blood flow in the epicardial artery. Then, the observation that MVO has profound negative structural and prognostic repercussions revived interest in microcirculation. In the near future, the availability of co-adjuvant therapies (beyond timely coronary reperfusion) aimed at preventing, minimizing, and repairing MVOs and finding convincing answers to questions regarding what, when, how, and where to administe…

medicine.medical_specialtymicrovascular obstructionlcsh:MedicineReview030204 cardiovascular system & hematologyMicrocirculation03 medical and health sciences0302 clinical medicineInternal medicinemedicineST segmentIn patient030212 general & internal medicineMyocardial infarctionbusiness.industrylcsh:RGeneral MedicineBlood flowreperfusion injurymedicine.diseasemyocardial infarctionmedicine.anatomical_structureCoronary occlusionCardiologybusinessReperfusion injuryArteryJournal of Clinical Medicine
researchProduct

Gender-Specific Metabolomics Approach to Kidney Cancer

2021

Renal cell carcinoma (RCC) is the most common form of kidney malignancy. RCC is more common among men with a 2/1 male/female incidence ratio worldwide. Given the underlying epidemiological differences in the RCC incidence between males and females, we explored the gender specific 1H NMR serum metabolic profiles of RCC patients and their matched controls. A number of differential metabolites were shared by male and female RCC patients. These RCC specific changes included lower lactate, threonine, histidine, and choline levels together with increased levels of pyruvate, N-acetylated glycoproteins, beta-hydroxybutyrate, acetoacetate, and lysine. Additionally, serum lactate/pyruvate ratio was a…

medicine.medical_specialtyrenal cell carcinomaEndocrinology Diabetes and MetabolismPhysiologyMalignancyurologic and male genital diseasesBiochemistryMicrobiologyArticlechemistry.chemical_compoundMetabolomicsmaleRenal cell carcinomaEpidemiologymedicinegenderCholineMolecular BiologyneoplasmsKidneybusiness.industryIncidence (epidemiology)medicine.diseaseRCCmetabolomicsQR1-502female genital diseases and pregnancy complicationsNMRmedicine.anatomical_structurefemalechemistrybusinessKidney cancerserumMetabolites
researchProduct

Vascular Adhesion Protein 1 Mediates Gut Microbial Flagellin-Induced Inflammation, Leukocyte Infiltration, and Hepatic Steatosis

2021

Toll-like receptor 5 ligand, flagellin, and vascular adhesion protein 1 (VAP-1) are involved in non-alcoholic fatty liver disease. This study aimed to determine whether VAP-1 mediates flagellin-induced hepatic fat accumulation. The effects of flagellin on adipocyte VAP-1 expression were first studied in vitro. Then, flagellin (100 ng/mouse) or saline was intraperitoneally injected into C57BL/6J (WT) and C57BL/6-Aoc3-/- (VAP-1 KO) mice on a high-fat diet twice a week every 2 weeks for 10 weeks. After that, the effects on inflammation, insulin signaling, and metabolism were studied in liver and adipose tissues. Hepatic fat was quantified histologically and biochemically. Because flagellin cha…

medicine.medical_specialtysuolistomikrobistoAdipose tissueInflammationliver03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAdipocyteInternal medicineMaterials ChemistrymedicineLipolysislcsh:Scienceaineenvaihdunta030304 developmental biology0303 health sciencesbiologygut microbiotatulehdusChemistryFatty livermaksamedicine.diseasebacterial infections and mycosesrespiratory tract diseasesEndocrinologyinflammation030220 oncology & carcinogenesisbiology.proteinlcsh:Qmedicine.symptomSteatosisHepatic fibrosismetabolismFlagellin
researchProduct

Hepatitis A infections from food.

2020

Food contaminated by hepatitis A virus (HAV) is responsible of the 2–7% of all HAV outbreaks worldwide. This review provides a description of the HAV characteristics, its infectivity and epidemiological features. In addition, this review compiles existing original papers reporting HAV prevalence, viral titres in foodstuffs and the risk associated with food contamination. The purpose of this revision is to conduct a structured and systematic review of the published molecular procedures for HAV detection in food, including the assessment of its infectivity.

medicine.medical_specialtyvirusesFood ContaminationApplied Microbiology and BiotechnologyRisk AssessmentDisease OutbreaksFoodborne Diseases03 medical and health sciencesEnvironmental healthEpidemiologymedicinePrevalenceFood microbiologyHumans030304 developmental biologyInfectivity0303 health sciences030306 microbiologybusiness.industryfungivirus diseasesOutbreakHepatitis AGeneral Medicinebiochemical phenomena metabolism and nutritionHepatitis Amedicine.diseasedigestive system diseasesHepatitis a virusFood MicrobiologyHepatitis A virusbusinessRisk assessmentBiotechnologyFood contaminantJournal of applied microbiologyReferences
researchProduct

Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant.

2004

Background Highly publicised outbreaks of norovirus gastroenteritis in hospitals in the UK and Ireland and cruise ships in the USA sparked speculation about whether this reported activity was unusual. Methods We analysed data collected through a collaborative research and surveillance network of viral gastroenteritis in ten European countries (England and Wales were analysed as one region). We compiled data on total number of outbreaks by month, and compared genetic sequences from the isolated viruses. Data were compared with historic data from a systematic retrospective review of surveillance systems and with a central database of viral sequences. Findings Three regions (England and Wales,…

medicine.medical_specialtyvirusesmedicine.disease_causeDisease Outbreaks03 medical and health sciencesEpidemiologyEpidemic spreadmedicineHumans030304 developmental biologyCaliciviridae InfectionsRetrospective Studies0303 health sciencesInternational network030306 microbiologybusiness.industryNorovirusGenetic variantsOutbreakGenetic VariationGeneral MedicineNew variantVirology3. Good healthGastroenteritisEuropePopulation SurveillanceMutationNorovirusFood MicrobiologyViral diseaseSeasonsbusinessLancet (London, England)
researchProduct

INHIBITION OF CELLULAR GROWTH AND STEROID 11β-HYDROXYLATION INRAS-TRANSFORMED ADRENOCORTICAL CELLS BY THE FUNGAL TOXINS BETICOLINS

1996

Abstract The proliferation of GM16 and 4CDTras-transformed newborn rat adrenocortical (RTAC) cells and Y1 mouse adrenal tumor cells was inhibited by beticolins, the fungal toxins extracted fromCercospora beticola, at submicromolar concentrations in a dose-dependent manner. Inhibitory concentrations for half the maximum inhibition were 150, 75 and 25 n M for beticolin-1 and 230, 150 and 50 n M for beticolin-2 in GM16, 4CDT and Y1 cells respectively. Beticolins strongly inhibited the production of 11β-hydroxysteroids on the second and third days of treatment in a dose-dependent manner between 0.1 and 1 μ M . Beticolins were shown by confocal microscopy to be localized in cytoplasmic organelle…

medicine.medical_treatmentAdrenal Gland NeoplasmsBiologyTransfectionHeterocyclic Compounds 4 or More RingsSteroidlaw.inventionHydroxylationMiceStructure-Activity Relationshipchemistry.chemical_compoundConfocal microscopylawOrganelleTumor Cells CulturedmedicineAnimalsCells CulturedHydroxysteroidsMicroscopy ConfocalDose-Response Relationship DrugCell growthCell BiologyGeneral MedicineMycotoxinsGrowth InhibitorsNeoplasm ProteinsRatsCell Transformation NeoplasticGenes rasAnimals NewbornchemistryBiochemistryCytoplasmAdrenal CortexSteroid 11-beta-HydroxylaseSignal transductionGrowth inhibitionCell DivisionCell Biology International
researchProduct

Intravenous SPION-labeled adipocyte-derived stem cells targeted to the brain by magnetic attraction in a rat stroke model: An ultrastructural insight…

2021

Abstract Mesenchymal stem cell therapy after stroke is a promising option investigated in animal models and clinical trials. The intravenous route is commonly used in clinical settings guaranteeing an adequate safety profile although low yields of engraftment. In this report, rats subjected to ischemic stroke were injected with adipose-derived stem cells (ADSCs) labeled with superparamagnetic iron oxide nanoparticles (SPIONs) applying an external magnetic field in the skull to retain the cells. Although most published studies demonstrate viability of ADSCs, only a few have used ultrastructural techniques. In our study, the application of a local magnetic force resulted in a tendency for hig…

medicine.medical_treatmentBiomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)BioengineeringCell fate determinationCorrelative microscopy Electron microscopy Magnetic fields SPION Stem cell therapy Strokechemistry.chemical_compoundAdipocyteAdipocytesmedicineAnimalsGeneral Materials ScienceMagnetite NanoparticlesStrokeMicrogliaStem CellsMesenchymal stem cellBrainStem-cell therapymedicine.diseaseMagnetic Resonance ImagingRatsCell biologyStrokeMagnetic Fieldsmedicine.anatomical_structurechemistryUltrastructureMolecular MedicineStem cellNanomedicine: Nanotechnology, Biology and Medicine
researchProduct

Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

2013

Molecular targeted therapy has shown promise as a treatment for advanced hepatocellular carcinoma (HCC). Sorafenib, a multikinase inhibitor, recently received FDA approval for the treatment of advanced HCC. However, although sorafenib is well tolerated, concern for its safety has been expressed. Celecoxib (Celebrex®) is a selective cyclooxygenase-2 (COX-2) inhibitor which exhibits antitumor effects in human HCC cells. The present study examined the interaction between celecoxib and sorafenib in two human liver tumor cell lines HepG2 and Huh7. Our data showed that each inhibitor alone reduced cell growth and the combination of celecoxib with sorafenib synergistically inhibited cell growth an…

medicine.medical_treatmentCancer TreatmentGene ExpressionApoptosisPharmacologyBiochemistryTargeted therapy0302 clinical medicineMolecular Cell Biology0303 health sciencesSulfonamidesMultidisciplinaryReverse Transcriptase Polymerase Chain ReactionQLiver NeoplasmsRDrug SynergismGenomicsSorafenib3. Good healthGene Expression Regulation NeoplasticOncology030220 oncology & carcinogenesisMedicineLiver cancermedicine.drugResearch ArticleBiotechnologySignal TransductionSorafenibNiacinamideProgrammed cell deathCarcinoma HepatocellularScienceBlotting WesternBiologyMolecular Genetics03 medical and health sciencesCell Line TumorGastrointestinal TumorsmedicineIn Situ Nick-End LabelingHumansneoplasmsBiology030304 developmental biologyCell ProliferationDNA PrimersHuman liver cancer Apoptosis Sorafenib Celecoxib anti-proliferative effectsCell growthGene Expression ProfilingPhenylurea CompoundsComputational BiologyCancers and NeoplasmsHepatocellular CarcinomaChemotherapy and Drug Treatmentmedicine.diseaseMicroarray Analysisdigestive system diseasesGene expression profilingApoptosisCell cultureCelecoxibPyrazolesGenome Expression AnalysisPLoS ONE
researchProduct

Immunologic microenvironment and personalized treatment in multiple myeloma.

2013

Introduction: Multiple myeloma (MM) is characterized by generalized immune suppression and increased susceptibility to infections and secondary malignancies. Malignant plasma cells (PCs) modulate the bone marrow microenvironment to favor their own survival and proliferation. These events lead to a severe deregulation of immune effectors. Extensive studies have been conducted to unveil the mechanisms through which MM cells negatively modulate immunity and to develop therapeutical approaches for restoring an efficient anti-MM immune response. Areas covered: This review article covers both the immunosuppressive effects exerted by MM and the immunomodulatory potential of novel anti-MM agents. A…

medicine.medical_treatmentClinical BiochemistryAntineoplastic AgentsImmune systemImmunityDrug DiscoveryTumor MicroenvironmentMedicineHumansPrecision MedicineMultiple myelomaBone marrow microenvironmentPharmacologyTumor microenvironmentbusiness.industryImmunotherapymedicine.diseaseReview articlemedicine.anatomical_structurePersonalized treatmentImmune SystemImmunologyBone marrowPersonalized medicineImmunotherapybusinessMultiple MyelomaExpert opinion on biological therapy
researchProduct